Annual Operating Expenses
$28.50 M
-$9.66 M-25.32%
31 December 2023
Summary:
Alaunos Therapeutics annual total operating expenses is currently $28.50 million, with the most recent change of -$9.66 million (-25.32%) on 31 December 2023. During the last 3 years, it has fallen by -$51.86 million (-64.54%). TCRT annual operating expenses is now -83.45% below its all-time high of $172.17 million, reached on 31 December 2016.TCRT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$1.15 M
-$20.00 K-1.71%
30 September 2024
Summary:
Alaunos Therapeutics quarterly total operating expenses is currently $1.15 million, with the most recent change of -$20.00 thousand (-1.71%) on 30 September 2024. Over the past year, it has dropped by -$6.08 million (-84.10%). TCRT quarterly operating expenses is now -99.13% below its all-time high of $132.94 million, reached on 30 June 2016.TCRT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRT Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.3% | -84.1% |
| 3 y3 years | -64.5% | -94.9% |
| 5 y5 years | -47.3% | -91.5% |
TCRT Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.5% | at low | -94.9% | at low |
| 5 y | 5 years | -64.5% | at low | -95.0% | at low |
| alltime | all time | -83.5% | >+9999.0% | -99.1% | >+9999.0% |
Alaunos Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.15 M(-1.7%) |
| June 2024 | - | $1.17 M(-32.9%) |
| Mar 2024 | - | $1.74 M(-48.1%) |
| Dec 2023 | $28.50 M(-25.3%) | $3.36 M(-53.5%) |
| Sept 2023 | - | $7.23 M(-12.1%) |
| June 2023 | - | $8.23 M(-14.9%) |
| Mar 2023 | - | $9.67 M(+13.4%) |
| Dec 2022 | $38.16 M(-50.6%) | $8.53 M(-23.7%) |
| Sept 2022 | - | $11.18 M(+19.3%) |
| June 2022 | - | $9.37 M(+3.1%) |
| Mar 2022 | - | $9.09 M(-11.9%) |
| Dec 2021 | $77.21 M(-3.9%) | $10.31 M(-54.6%) |
| Sept 2021 | - | $22.69 M(+0.2%) |
| June 2021 | - | $22.64 M(+5.0%) |
| Mar 2021 | - | $21.56 M(-5.3%) |
| Dec 2020 | $80.36 M(+38.9%) | $22.77 M(+12.1%) |
| Sept 2020 | - | $20.32 M(+9.2%) |
| June 2020 | - | $18.61 M(-0.3%) |
| Mar 2020 | - | $18.66 M(+16.4%) |
| Dec 2019 | $57.86 M(+7.0%) | $16.04 M(+19.2%) |
| Sept 2019 | - | $13.45 M(-8.8%) |
| June 2019 | - | $14.75 M(+8.3%) |
| Mar 2019 | - | $13.62 M(+6.7%) |
| Dec 2018 | $54.05 M(-9.7%) | $12.76 M(+1.5%) |
| Sept 2018 | - | $12.57 M(+1.6%) |
| June 2018 | - | $12.38 M(-24.3%) |
| Mar 2018 | - | $16.34 M(+8.7%) |
| Dec 2017 | $59.88 M(-65.2%) | $15.03 M(+2.4%) |
| Sept 2017 | - | $14.68 M(+0.4%) |
| June 2017 | - | $14.61 M(-6.1%) |
| Mar 2017 | - | $15.56 M(+22.5%) |
| Dec 2016 | $172.17 M(+38.4%) | $12.71 M(+1.6%) |
| Sept 2016 | - | $12.51 M(-90.6%) |
| June 2016 | - | $132.94 M(+849.0%) |
| Mar 2016 | - | $14.01 M(+22.9%) |
| Dec 2015 | $124.43 M(+177.3%) | $11.40 M(-43.1%) |
| Sept 2015 | - | $20.04 M(+38.2%) |
| June 2015 | - | $14.50 M(-81.5%) |
| Mar 2015 | - | $78.50 M(+617.8%) |
| Dec 2014 | $44.87 M(-23.3%) | $10.94 M(-13.0%) |
| Sept 2014 | - | $12.57 M(+10.5%) |
| June 2014 | - | $11.38 M(+14.0%) |
| Mar 2014 | - | $9.98 M(+44.3%) |
| Dec 2013 | $58.51 M(-43.2%) | $6.92 M(-25.7%) |
| Sept 2013 | - | $9.31 M(-49.6%) |
| June 2013 | - | $18.50 M(-22.2%) |
| Mar 2013 | - | $23.78 M(-39.1%) |
| Dec 2012 | $102.97 M | $39.04 M(+78.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $21.93 M(-5.3%) |
| June 2012 | - | $23.17 M(+23.0%) |
| Mar 2012 | - | $18.83 M(+13.3%) |
| Dec 2011 | $72.07 M(+193.6%) | $16.62 M(+15.3%) |
| Sept 2011 | - | $14.41 M(+10.4%) |
| June 2011 | - | $13.05 M(-53.4%) |
| Mar 2011 | - | $27.99 M(+340.1%) |
| Dec 2010 | $24.55 M(+102.5%) | $6.36 M(-25.2%) |
| Sept 2010 | - | $8.50 M(+66.1%) |
| June 2010 | - | $5.12 M(+12.0%) |
| Mar 2010 | - | $4.57 M(+13.4%) |
| Dec 2009 | $12.12 M(-52.7%) | $4.03 M(+56.8%) |
| Sept 2009 | - | $2.57 M(+17.2%) |
| June 2009 | - | $2.19 M(-34.2%) |
| Mar 2009 | - | $3.33 M(-27.0%) |
| Dec 2008 | $25.62 M(-10.3%) | $4.56 M(-18.8%) |
| Sept 2008 | - | $5.62 M(-15.1%) |
| June 2008 | - | $6.62 M(-25.0%) |
| Mar 2008 | - | $8.82 M(+8.9%) |
| Dec 2007 | $28.57 M(+49.5%) | $8.10 M(+3.0%) |
| Sept 2007 | - | $7.86 M(+9.3%) |
| June 2007 | - | $7.20 M(+32.8%) |
| Mar 2007 | - | $5.42 M(-12.9%) |
| Dec 2006 | $19.11 M(+95.3%) | $6.22 M(+58.3%) |
| Sept 2006 | - | $3.93 M(-30.9%) |
| June 2006 | - | $5.69 M(+73.8%) |
| Mar 2006 | - | $3.27 M(+28.2%) |
| Dec 2005 | $9.79 M(+71.5%) | $2.55 M(-10.7%) |
| Sept 2005 | - | $2.86 M(+35.6%) |
| June 2005 | - | $2.11 M(-6.9%) |
| Mar 2005 | - | $2.26 M(-14.1%) |
| Dec 2004 | $5.71 M(+3454.5%) | $2.64 M(+94.8%) |
| Sept 2004 | - | $1.35 M(+8255.6%) |
| June 2004 | - | $16.20 K(+145.5%) |
| Mar 2004 | - | $6600.00(-95.1%) |
| Dec 2003 | $160.60 K(+277.9%) | $135.60 K(+1495.3%) |
| Sept 2003 | - | $8500.00(+28.8%) |
| June 2003 | - | $6600.00(-33.3%) |
| Mar 2003 | - | $9900.00(-8.3%) |
| Dec 2002 | $42.50 K(-42.8%) | $10.80 K(+63.6%) |
| Sept 2002 | - | $6600.00(-54.2%) |
| June 2002 | - | $14.40 K(+33.3%) |
| Mar 2002 | - | $10.80 K(-73.5%) |
| Dec 2001 | $74.30 K | $40.70 K(+442.7%) |
| Sept 2001 | - | $7500.00(-39.5%) |
| June 2001 | - | $12.40 K(-9.5%) |
| Mar 2001 | - | $13.70 K(+61.2%) |
| Sept 2000 | - | $8500.00(-74.3%) |
| June 2000 | - | $33.10 K |
FAQ
- What is Alaunos Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual operating expenses year-on-year change?
- What is Alaunos Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly operating expenses year-on-year change?
What is Alaunos Therapeutics annual total operating expenses?
The current annual operating expenses of TCRT is $28.50 M
What is the all time high annual operating expenses for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual total operating expenses is $172.17 M
What is Alaunos Therapeutics annual operating expenses year-on-year change?
Over the past year, TCRT annual total operating expenses has changed by -$9.66 M (-25.32%)
What is Alaunos Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of TCRT is $1.15 M
What is the all time high quarterly operating expenses for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly total operating expenses is $132.94 M
What is Alaunos Therapeutics quarterly operating expenses year-on-year change?
Over the past year, TCRT quarterly total operating expenses has changed by -$6.08 M (-84.10%)